This inventor holds 1 USPTO granted patent, plus 1 CIPO patent and 1 EPO patent. Top assignees: Celgene Corporation, Washington University. Active years: 2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 561 
1 out of 1,381 
Years Active: 2023
Title: Innovations in Cardiovascular Treatment by Keith Hruska
Introduction
Keith Hruska is an accomplished inventor based in Creve Coeur, MO (US). He has made significant contributions to the field of cardiovascular disease treatment. His innovative approach focuses on utilizing biomarker levels to enhance treatment efficacy and dosage accuracy.
Latest Patents
Hruska holds a patent for the "Treatment of cardiovascular disease using ActRII ligand traps." This patent outlines methods for treating diseases associated with vascular calcification and cardiovascular conditions. The methods involve using various biomarkers, such as snail homolog 1 (Snai1), phosphosmad2, and activin receptor type 2A (ActRIIA), to assess treatment responsiveness and efficacy.
Career Highlights
Throughout his career, Hruska has worked with notable organizations, including Celgene Corporation and Washington University. His experience in these institutions has allowed him to develop and refine his innovative approaches to treating cardiovascular diseases.
Collaborations
Hruska has collaborated with esteemed colleagues, including William H. Smith and Yifu Fang. These partnerships have contributed to the advancement of his research and the development of effective treatment methods.
Conclusion
Keith Hruska's work in cardiovascular treatment exemplifies the impact of innovation in medicine. His patent and career achievements highlight the importance of research and collaboration in advancing healthcare solutions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile